Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina
- PMID: 35034617
- PMCID: PMC8761334
- DOI: 10.1186/s12879-022-07038-6
Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina
Abstract
Background: Many studies examined the spread of SARS-CoV-2 within populations using seroprevalence. Healthcare workers are a high-risk population due to patient contact, and studies are needed to examine seroprevalence of SARS-CoV-2 antibodies among healthcare workers. Our study investigates the seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina, and factors associated with seroprevalence.
Methods: We carried out a cross-sectional survey including SARS-CoV-2 serological testing and questionnaires with primary healthcare workers from primary healthcare facilities in the Prishtina, the capital city of Kosovo. We calculated prevalence of anti-SARS-CoV-2 antibodies, and of self-reported positive PCR test among primary healthcare workers, as well as crude and adjusted ORs for explanatory factors.
Results: Eighty-three of the healthcare workers (17.47%) tested positive for SARS-CoV-2 antibodies IgG or IgM, while 231 (48.63%) either had antibodies or a previous positive PCR test. Odds of seropositivity were affected by male gender (OR 2.08, 95% CI 1.20, 3.61), and infected family members (OR 3.61, 95% CI 2.25, 5.79) of healthcare workers. Higher education, being part of larger families and having infected family members gave higher odds of positive PCR test and seropositivity. Other healthcare workers had lower odds of positive PCR test and seropositivity than physicians.
Conclusion: Over 17% of healthcare workers were seropositive for SARS-CoV-2 antibodies and close to half of them were either seropositive or PCR self-reported positive test. Several factors are associated with decreased and increased odds for such outcomes. These findings should be explored further and addressed to Kosovo policy makers, and assist them to intensify vaccination efforts, and maintain control measures until we achieve herd immunity.
Keywords: COVID-19; Epidemiology; Healthcare workers; Infectious diseases; Public Health; Serology.
© 2022. The Author(s).
Conflict of interest statement
The authors have no competing interests.
Similar articles
-
Seroprevalence of Anti-SARS-CoV-2 Antibodies among Municipal Staff in the Municipality of Prishtina.Int J Environ Res Public Health. 2021 Nov 28;18(23):12545. doi: 10.3390/ijerph182312545. Int J Environ Res Public Health. 2021. PMID: 34886272 Free PMC article.
-
SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.Ann Med. 2021 Dec;53(1):1956-1959. doi: 10.1080/07853890.2021.1993325. Ann Med. 2021. PMID: 34727801 Free PMC article.
-
Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.Front Public Health. 2022 Oct 6;10:967447. doi: 10.3389/fpubh.2022.967447. eCollection 2022. Front Public Health. 2022. PMID: 36276377 Free PMC article.
-
Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis.J Clin Nurs. 2022 Jun;31(11-12):1557-1569. doi: 10.1111/jocn.16009. Epub 2021 Sep 27. J Clin Nurs. 2022. PMID: 34570947 Free PMC article.
-
Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis.Int J Environ Res Public Health. 2022 Jun 14;19(12):7257. doi: 10.3390/ijerph19127257. Int J Environ Res Public Health. 2022. PMID: 35742506 Free PMC article.
Cited by
-
Severe acute respiratory syndrome coronavirus 2 seroprevalence among patients with pulmonary tuberculosis.Rev Assoc Med Bras (1992). 2023 Sep 18;69(9):e20230661. doi: 10.1590/1806-9282.20230661. eCollection 2023. Rev Assoc Med Bras (1992). 2023. PMID: 37729381 Free PMC article.
-
Risk of COVID-19 infection among frontline healthcare workers during the COVID-19 pandemic.World J Virol. 2025 Jun 25;14(2):99663. doi: 10.5501/wjv.v14.i2.99663. World J Virol. 2025. PMID: 40575632 Free PMC article.
-
SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave.Sci Rep. 2024 Mar 5;14(1):5418. doi: 10.1038/s41598-024-55477-9. Sci Rep. 2024. PMID: 38443618 Free PMC article.
-
SARS-CoV-2 seroprevalence and infection rate in Manila, Philippines prior to national vaccination program implementation: a repeated cross-sectional analysis.Trop Med Health. 2022 Oct 11;50(1):75. doi: 10.1186/s41182-022-00468-7. Trop Med Health. 2022. PMID: 36221142 Free PMC article.
-
Serology as a Tool to Assess Infectious Disease Landscapes and Guide Public Health Policy.Pathogens. 2022 Jun 27;11(7):732. doi: 10.3390/pathogens11070732. Pathogens. 2022. PMID: 35889978 Free PMC article. Review.
References
-
- WHO . COVID-19 dashboard. Geneva: World Health Organization; 2020.
-
- Tanne JH, Hayasaki E, Zastrow M, Pulla P, Smith P, Rada AG. Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide. BMJ. 2020;368:m1090. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous